Sundaram Multi Pap Limited — Important, 14-02-2025: Financial Result Updates

For the quarter ended December 31, 2024, Sundaram Multi Pap Limited reported total revenue from operations of ₹2,135.53 cr, reflecting a slight decline compared to ₹2,194.49 cr in the same quarter of the previous year. The year-to-date revenue stands at ₹8,777.71 cr, up from ₹8,653.89 cr, indicating a year-over-year growth of approximately 1.4%. Key factors driving revenue performance include stabilization in operational demand amidst fluctuations in raw material costs and adjustments in inventory management.

Net loss for the quarter narrowed slightly to ₹268.53 cr from a loss of ₹214.24 cr in the corresponding period last year. Year-to-date, the net loss is reported at ₹426.81 cr, a reduction compared to ₹531.80 cr in the same period last year. Basic and diluted EPS for the quarter are both at ₹(0.057).

Operational costs saw a reduction of approximately 6.2% when compared to the previous quarter, primarily due to better inventory management and streamlining of operational expenses. However, total expenses increased overall, driven by higher costs of materials consumed, which reached ₹2,119.87 cr.

The balance sheet indicates a continued reliance on debt, reflecting high leverage levels, which may pose challenges in cash flow management moving forward. The company's strategic outlook focuses on cost control and gradual market recovery as demand stabilizes.

Investor insight leans towards a cautious approach, suggesting a hold position due to ongoing operational challenges but acknowledging potential recovery as market conditions improve.